Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026)
Dr Reddys Laboratories (RDY) recorded Share-based Compensation of $1.02 million in the quarter ended Jun 30, 2026, down 21.7% from $1.31 million a year earlier.
Dr Reddys Laboratories (RDY) Share-based Compensation (2009 - 2026) Analysis & Trends
On a TTM basis, Dr Reddys Laboratories' Share-based Compensation came in at $4.76 million as of Jun 30, 2026, down 4.2% year-over-year; for the year ended Mar 31, 2026, it was $3 million, down 40.0% from the prior year.
- Annual Share-based Compensation has a five-year compound annual growth rate of -17.8% (years ended Mar 2021 to Mar 2026).
- Across earlier years, Share-based Compensation came in at $5 million in the year ended Mar 31, 2025 (unchanged), $5 million in the year ended Mar 31, 2024 (unchanged), $5 million in the year ended Mar 31, 2023 (-37.5%) and $8 million in the year ended Mar 31, 2022 (unchanged).
- The figure for the quarter ended Jun 30, 2026 is the lowest quarterly Share-based Compensation since the quarter ended Mar 31, 2023.
- On a year-over-year basis, Share-based Compensation rose in two of the last four quarters, with an average decline of 5.3%.
- Peak year-over-year performance for Share-based Compensation in the last five years was growth of 357.2% in the quarter ended Mar 31, 2024, against a decline of 86.4% in the quarter ended Mar 31, 2023 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 458.00 Mn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 166.00 Mn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 298.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | - |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 165.00 Mn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 231.00 Mn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 249.00 Mn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 170.20 Mn |
| 10 | Dr Reddys Laboratories | 10.44 Bn | 9.62 Bn | 396.53 Mn | 1.02 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.02 Mn |
| Sep 30, 2025 | 1.15 Mn |
| Jun 30, 2025 | 1.31 Mn |
| Sep 30, 2024 | 1.28 Mn |
| Jun 30, 2024 | 1.21 Mn |
| Mar 31, 2024 | 1.17 Mn |
| Dec 31, 2023 | 1.19 Mn |
| Sep 30, 2023 | 1.25 Mn |
| Jun 30, 2023 | 1.31 Mn |
| Mar 31, 2023 | 255,461.90 |
| Dec 31, 2022 | 1.38 Mn |
| Sep 30, 2022 | 1.47 Mn |
| Jun 30, 2022 | 1.89 Mn |
| Mar 31, 2022 | 1.88 Mn |
| Dec 31, 2021 | 2.15 Mn |
| Sep 30, 2021 | 1.93 Mn |
| Jun 30, 2021 | 1.99 Mn |
| Mar 31, 2021 | 1.77 Mn |
| Dec 31, 2020 | 2.04 Mn |
| Sep 30, 2020 | 2.16 Mn |
Dr Reddys Laboratories Share-based Compensation API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation", "ticker": "RDY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation&ticker=RDY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();